Literature DB >> 15321960

Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models.

C H Cole1, J P Mitchell, M P Foley, M W Nagel.   

Abstract

Dose delivery of hydrofluoroalkane-beclomethasone and chlorofluorocarbon-beclomethasone was compared during in vitro neonatal simulations: mechanical ventilation with 40% and 100% relative humidity + Neonatal Chamber-Ventilator System/endotracheal tube; manual ventilation + Neonatal Chamber/endotracheal tube; "spontaneous breathing" + Neonatal Chamber/face mask without/with manual assistance. The delivery of hydrofluoroalkane-beclomethasone was significantly greater in each simulation.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321960      PMCID： PMC1721739          DOI： 10.1136/adc.2002.022905

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


  3 in total

Review 1.  New delivery systems and propellants.

Authors:  M Dolovich
Journal:  Can Respir J       Date:  1999 May-Jun       Impact factor: 2.409

2.  Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome.

Authors:  T F Fok; K Lam; M Dolovich; P C Ng; W Wong; K L Cheung; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

3.  Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.

Authors:  C H Cole; T Colton; B L Shah; S Abbasi; B L MacKinnon; S Demissie; I D Frantz
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245
  3 in total
  1 in total

1.  Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot study.

Authors:  A Kugelman; M Peniakov; S Zangen; Y Shiff; A Riskin; A Iofe; I Shoris; D Bader; S Arnon
Journal:  J Perinatol       Date:  2016-10-13       Impact factor: 2.521
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.